Literature DB >> 21360704

PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.

Natascha de Graaf1, Mary J G van Helden, Kathrin Textoris-Taube, Tomoki Chiba, David J Topham, Peter-Michael Kloetzel, Dietmar M W Zaiss, Alice J A M Sijts.   

Abstract

Proteasomes play a fundamental role in the processing of intracellular antigens into peptides that bind to MHC class I molecules for the presentation of CD8(+) T cells. Three IFN-γ-inducible catalytic proteasome (immuno)subunits as well as the IFN-γ-inducible proteasome activator PA28 dramatically accelerate the generation of a subset of MHC class I-presented antigenic peptides. To determine whether these IFN-γ-inducible proteasome components play a compounded role in antigen processing, we generated mice lacking both PA28 and immunosubunits β5i/LMP7 and β2i/MECL-1. Analyses of MHC class I cell-surface levels ex vivo demonstrated that PA28 deficiency reduced the production of MHC class I-binding peptides both in cells with and without immunosubunits, in the latter cells further decreasing an already diminished production of MHC ligands in the absence of immunoproteasomes. In contrast, the immunosubunits but not PA28 appeared to be of critical importance for the induction of CD8(+) T-cell responses to multiple dominant Influenza and Listeria-derived epitopes. Taken together, our data demonstrate that PA28 and the proteasome immunosubunits use fundamentally different mechanisms to enhance the supply of MHC class I-binding peptides; however, only the immunosubunit-imposed effects on proteolytic epitope processing appear to have substantial influence on the specificity of pathogen-specific CD8(+) T-cell responses.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360704      PMCID: PMC3100532          DOI: 10.1002/eji.201041040

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  Proteasome activator 11S REG or PA28: recombinant REG alpha/REG beta hetero-oligomers are heptamers.

Authors:  Z Zhang; A Krutchinsky; S Endicott; C Realini; M Rechsteiner; K G Standing
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

Review 2.  Structure and functions of the 20S and 26S proteasomes.

Authors:  O Coux; K Tanaka; A L Goldberg
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

3.  Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.

Authors:  T P Dick; T Ruppert; M Groettrup; P M Kloetzel; L Kuehn; U H Koszinowski; S Stevanović; H Schild; H G Rammensee
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

4.  Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.

Authors:  N Shimbara; H Nakajima; N Tanahashi; K Ogawa; S Niwa; A Uenaka; E Nakayama; K Tanaka
Journal:  Genes Cells       Date:  1997-12       Impact factor: 1.891

5.  MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL.

Authors:  Y Deng; J W Yewdell; L C Eisenlohr; J R Bennink
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

6.  Expression and subcellular localization of mouse 20S proteasome activator complex PA28.

Authors:  A Soza; C Knuehl; M Groettrup; P Henklein; K Tanaka; P M Kloetzel
Journal:  FEBS Lett       Date:  1997-08-11       Impact factor: 4.124

7.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

Authors:  L Van Kaer; P G Ashton-Rickardt; M Eichelberger; M Gaczynska; K Nagashima; K L Rock; A L Goldberg; P C Doherty; S Tonegawa
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

8.  MHC class I expression in mice lacking the proteasome subunit LMP-7.

Authors:  H J Fehling; W Swat; C Laplace; R Kühn; K Rajewsky; U Müller; H von Boehmer
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

9.  Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system.

Authors:  G Niedermann; R Grimm; E Geier; M Maurer; C Realini; C Gartmann; J Soll; S Omura; M C Rechsteiner; W Baumeister; K Eichmann
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

10.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits.

Authors:  T A Griffin; D Nandi; M Cruz; H J Fehling; L V Kaer; J J Monaco; R A Colbert
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  25 in total

Review 1.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.

Authors:  Masanori Kasahara; Martin F Flajnik
Journal:  Immunogenetics       Date:  2019-01-24       Impact factor: 2.846

3.  Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.

Authors:  M Cecilia Poli; Frédéric Ebstein; Sarah K Nicholas; Marietta M de Guzman; Lisa R Forbes; Ivan K Chinn; Emily M Mace; Tiphanie P Vogel; Alexandre F Carisey; Felipe Benavides; Zeynep H Coban-Akdemir; Richard A Gibbs; Shalini N Jhangiani; Donna M Muzny; Claudia M B Carvalho; Deborah A Schady; Mahim Jain; Jill A Rosenfeld; Lisa Emrick; Richard A Lewis; Brendan Lee; Barbara A Zieba; Sébastien Küry; Elke Krüger; James R Lupski; Bret L Bostwick; Jordan S Orange
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

4.  Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases.

Authors:  Dietmar M W Zaiss; Cornelis P J Bekker; Andrea Gröne; Benedicte A Lie; Alice J A M Sijts
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

5.  The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways.

Authors:  Jennifer R Tisoncik; Rosalind Billharz; Svetlana Burmakina; Sarah E Belisle; Sean C Proll; Marcus J Korth; Adolfo García-Sastre; Michael G Katze
Journal:  J Gen Virol       Date:  2011-05-18       Impact factor: 3.891

6.  Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation.

Authors:  Ziyou Cui; Soyun Michelle Hwang; Aldrin V Gomes
Journal:  Mol Cell Biol       Date:  2013-10-28       Impact factor: 4.272

7.  Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus.

Authors:  Cristina Pintado; María P Gavilán; Elena Gavilán; Luisa García-Cuervo; Antonia Gutiérrez; Javier Vitorica; Angélica Castaño; Rosa M Ríos; Diego Ruano
Journal:  J Neuroinflammation       Date:  2012-05-04       Impact factor: 8.322

Review 8.  Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases.

Authors:  Anja Brehm; Elke Krüger
Journal:  Semin Immunopathol       Date:  2015-05-12       Impact factor: 11.759

9.  Immunoproteasome-deficiency has no effects on NK cell education, but confers lymphocytes into targets for NK cells in infected wild-type mice.

Authors:  Mary J G van Helden; Natascha de Graaf; Cornelis P J Bekker; Claire J P Boog; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

10.  Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex.

Authors:  Chris Pickering; Mia Ericson; Bo Söderpalm
Journal:  ISRN Psychiatry       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.